CNS Pharmaceuticals, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • CNS Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $818.000, a 36% decline year-over-year.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2023 was $4.13K, a 64.8% decline from 2022.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2022 was $11.8K, a 10.1% decline from 2021.
  • CNS Pharmaceuticals, Inc. annual Depreciation for 2021 was $13.1K, a 17.8% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.13K -$7.62K -64.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $11.8K -$1.31K -10.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $13.1K +$1.97K +17.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $11.1K +$9.14K +468% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $1.96K +$1.96K Jan 1, 2019 Dec 31, 2019 10-K 2021-02-12
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.